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Context
Otitis media with effusion (OME) is deﬁned as accumulation of ﬂuid in the
middle ear in absence of signs or symptoms of an acute ear infection.1
OME is usually associated with a conductive hearing loss that may affect
the quality of life.1 Surgical treatment of OME with grommets is associated
with substantial healthcare costs and is usually considered after a period
of watchful waiting, leaving most children with OME untreated during this
period.1 This raises the need for an efﬁcient, non-invasive treatment
option that can be offered to children with OME at an early stage.
In 1968, Hunt-Williams presented a new method for autoinﬂation
involving a plastic end-piece connected to a balloon, later developed into
the Otovent device.2 The present study evaluates the effect of autoinﬂa-
tion with this method on children with OME.
Methods
This was a randomised controlled trial (RCT) set in 43 family practices in
the UK including 320 children aged 4–11 years with otitis media with
effusion in one or both ears, conﬁrmed by tympanometry.
The plastic end-piece in the Otovent device was adapted to a nostril
and, while the other nostril was occluded, the children were instructed to
inﬂate the balloon. The children were allocated to either autoinﬂation
three times daily for 1–3 months in addition to usual care (intervention) or
usual care alone (control). Clearance of middle-ear ﬂuid at 1 and 3 months
was evaluated by tympanometry. Ear-related quality of life was assessed
at 3 months using the OMQ-14 (an ear-related measure of quality of life).
The results are reported as relative risk (RR) or OR estimates and CIs. The
methodology is adhered to recognised international protocols for RCTs.
Findings
Children performing autoinﬂation were more likely to achieve a normal
tympanogram at 1 month compared to controls (47.3% (62/131) vs
35.6% (47/132); adjusted relative risk (RR) 1.36, 95% CI 0.99 to 1.88) and
at 3 months (49.6% (62/125) vs 38.3% (46/120); adjusted RR 1.37, 95%
CI 1.03 to 1.83). The improvement in ear-related quality of life, as judged
by OMQ-14, was superior in the autoinﬂation group compared to the
control group (score −0.42, 95% CI −0.63 to −0.22). Compliance was
89% at 1 month and 80% at 3 months. There was no signiﬁcant differ-
ence in adverse events between the groups.
Commentary
This RTC evaluated the effect of autoinﬂation with the Otovent device on
children with OME, and achieved some positive results. However, only
children aged 4–11 years were included, while OME culminates between
the ages of 1–4 years with decreasing prevalence thereafter.3
Additionally, the primary indication for treatment of OME is the restor-
ation of normal hearing,1 yet hearing testing was not performed in this
study. The follow-up period was also limited to 3 months, making it
impossible to evaluate the long-term outcome of this treatment.
The most recent Cochrane review gave a relatively weak recommenda-
tion regarding autoinﬂation in treatment for children with OME based on
the short follow-up time and the lack of adequate hearing evaluation in
previous studies.4 An efﬁcient treatment for OME should be appropriate
for children younger than 4 years of age and the study protocol should
include hearing testing and a long-term follow-up.5
This study shows that autoinﬂation reduces middle ear effusion and
improves the quality of life in children with OME.
The large sample size from family practices may permit generalisation
of the results to a normal population. The simplicity of the Otovent device
allows for early intervention during the watchful waiting period. Future
studies should assess the effect on hearing and the long-term outcome.
Implications for practice
This study provides evidence that autoinﬂation may reduce middle ear effu-
sion and the related symptoms in some children with OME. Given its low
cost and non-invasive character, it may be reasonable to apply this method
to improve symptoms and hopefully avoid surgery in children with OME.
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